Citius Oncology, Inc.(CTOR)

Medical - Pharmaceuticals · Cranford, NY

$0.85-0.02 (-2.69%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Citius Oncology (CTOR) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T20:31:05.562Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:31:05.562Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.85
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.4777

FMP input reference: e47236677832b0178bb4e4de0ecbdefb2e069a6eb9feaf5a3a870b06349bdf9c

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

CTOR PE Ratio Metrics

PE RATIO

N/A

CTOR Competitors' PE Ratio

CTOR

Citius Oncology, Inc.

Current

Market Cap

$79.03M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VTVT

vTv Therapeutics Inc.

vs CTOR

Market Cap

$78.59M

PE Ratio

N/A

TTM Avg

1681.60

3Y Avg

1681.60

5Y Avg

1681.60

ACRV

Acrivon Therapeutics, Inc. Common Stock

vs CTOR

Market Cap

$79.61M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SERA

Sera Prognostics, Inc.

vs CTOR

Market Cap

$78.29M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INO

Inovio Pharmaceuticals, Inc.

vs CTOR

Market Cap

$78.07M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HUMA

Humacyte, Inc.

vs CTOR

Market Cap

$80.30M

PE Ratio

N/A

TTM Avg

8.03

3Y Avg

8.03

5Y Avg

8.03

NTHI

Neonc Technologies Holdings, Inc.

vs CTOR

Market Cap

$77.54M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NTRB

Nutriband Inc.

vs CTOR

Market Cap

$81.20M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MNOV

MediciNova, Inc.

vs CTOR

Market Cap

$81.22M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Outset Medical, Inc.

vs CTOR

Market Cap

$76.74M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Citius Oncology, Inc. (CTOR)	$79.03M	N/A	N/A	N/A	N/A
vTv Therapeutics Inc. (VTVT)vs ›	$78.59M	N/A	1681.60	1681.60	1681.60
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$79.61M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$78.29M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$78.07M	N/A	N/A	N/A	N/A
Humacyte, Inc. (HUMA)vs ›	$80.30M	N/A	8.03	8.03	8.03
Neonc Technologies Holdings, Inc. (NTHI)vs ›	$77.54M	N/A	N/A	N/A	N/A
Nutriband Inc. (NTRB)vs ›	$81.20M	N/A	N/A	N/A	N/A
MediciNova, Inc. (MNOV)vs ›	$81.22M	N/A	N/A	N/A	N/A
Outset Medical, Inc. (OM)vs ›	$76.74M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

8.5

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.85

Forward EPS (Est.)

$0.10

Forward P/E

8.50

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

CTOR PE Ratio Metrics

CTOR Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics